MERCAPTOPURINE Side Effects

7014332-4 | Alopecia, Bone Marrow Failure, Escherichia Sepsis, Pancytopenia, Upper Respiratory Tract Infection
on Sep 23, 2010 Female patient from , 13 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, bone marrow failure, escherichia sepsis, pancytopenia, upper respiratory tract infection. Mercaptopurine dosage: . During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

7013395-X | Diarrhoea, Myelodysplastic Syndrome
Patient was taking Mercaptopurine (View Usage). Patient had the following side effects: diarrhoea, myelodysplastic syndrome on Sep 23, 2010 from Additional patient health information: Male patient , 14 years of age, was diagnosed with crohn's disease (What is crohn's disease?), diarrhoea and. Mercaptopurine dosage: 50 Mg. During the same period patient was treated with ANTI TNF (View Anti-tnf Review and Anti-tnf Label ).

7006056-4 | Acute Myeloid Leukaemia
Adverse event was reported on Sep 07, 2010 by a Female patient taking Mercaptopurine (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: ITALY , 21 years of age, After Mercaptopurine was administered, patient had the following side effects: acute myeloid leukaemia. During the same period patient was treated with TUMOR NECROSIS FACTOR ALPHA (TNF ALPHA) INHIB (View Tumor Necrosis Factor Alpha (tnf-alpha) Inhib Review and Tumor Necrosis Factor Alpha (tnf-alpha) Inhib Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), MESALAZINE (View Mesalazine Review and Mesalazine Label ), ENTOCORT EC (View Entocort Ec Review and Entocort Ec Label ).

7006051-5 | Myelodysplastic Syndrome
on Sep 07, 2010 Male patient from ITALY , 14 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: myelodysplastic syndrome. Mercaptopurine dosage: . During the same period patient was treated with TUMOR NECROSIS FACTOR ALPHA (TNF ALPHA) INHIB (Weekly Tnf-alpha-inhibitor (100mg)) (View Tumor Necrosis Factor Alpha (tnf-alpha) Inhib Review and Tumor Necrosis Factor Alpha (tnf-alpha) Inhib Label ).


6981372-0 | Visceral Leishmaniasis
on Aug 31, 2010 Female patient from SPAIN , 75 years of age, was diagnosed with autoimmune hepatitis and was treated with Mercaptopurine (View Usage). Patient had the following side effects: visceral leishmaniasis. Mercaptopurine dosage: (0.75 Mg/kg/day). Patient was hospitalized.

6971900-3 | Hyperbilirubinaemia
Patient was taking Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: hyperbilirubinaemia on Sep 08, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 117.1 lb, . Mercaptopurine dosage: 12600 Mg. During the same period patient was treated with METHOTREXATE (440 Mg) (View Methotrexate Review and Methotrexate Label ), PREDNISONE (900 Mg) (View Prednisone Review and Prednisone Label ), VINCRISTINE SULFATE (6 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ).

6959026-6 | Hepatosplenic T-cell Lymphoma
Adverse event was reported on Aug 17, 2010 by a Male patient taking Mercaptopurine (View Usage) (Dosage: 25mg Alternating With 50mg Every Other Day) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 18 years of age, Patient experienced the following unwanted or unexpected effects: hepatosplenic t-cell lymphoma.

6956969-4 | Acute Lymphocytic Leukaemia Recurrent, Constipation
on Aug 27, 2010 Female patient from UNITED STATES , weighting 257.5 lb, was treated with Mercaptopurine (View Usage). Patient had the following side effects: acute lymphocytic leukaemia recurrent, constipation (What is constipation?). Mercaptopurine dosage: 5100 Mg. During the same period patient was treated with METHOTREXATE (195 Mg) (View Methotrexate Review and Methotrexate Label ), VINCRISTINE SULFATE (1.74 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DEXAMETHASONE (91 Mg) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6942484-0 | Febrile Neutropenia, Hepatosplenic T-cell Lymphoma, Pancytopenia, Treatment Failure
on Aug 23, 2010 Male patient from , 13 years of age, was diagnosed with crohn's disease (What is crohn's disease?), hepatosplenic t-cell lymphoma and was treated with Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: febrile neutropenia, hepatosplenic t-cell lymphoma, pancytopenia, treatment failure. Mercaptopurine dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), PENTOSTATIN (View Pentostatin Review and Pentostatin Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), BUSULFAN (View Busulfan Review and Busulfan Label ).

6941332-2 | Hepatosplenic T-cell Lymphoma
Patient was taking Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatosplenic t-cell lymphoma on Aug 16, 2010 from UNITED STATES Additional patient health information: Male patient , 18 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Mercaptopurine dosage: Alternating.

6940761-0 | Hypoaesthesia, Paraesthesia, Psychomotor Hyperactivity, Tension
Adverse event was reported on Apr 09, 2010 by a Male patient taking Mercaptopurine (View Usage) (Dosage: ) was diagnosed with proctitis and. Location: UNITED STATES , 52 years of age, weighting 170.0 lb, Patient had the following side effects: hypoaesthesia, paraesthesia, psychomotor hyperactivity, tension. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CIALIS (View Cialis Review and Cialis Label ), KAPIDEX (View Kapidex Review and Kapidex Label ), LIALDA (View Lialda Review and Lialda Label ), GLUCOSAMINE + CHONDROITIN (View Glucosamine + Chondroitin Review and Glucosamine + Chondroitin Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ).

6937803-5 | Cardiac Flutter, Diarrhoea, Dyspnoea, Haematocrit Decreased, Haemoglobin Decreased, Hypophagia, Liver Function Test Abnormal, Nausea, No Therapeutic Response
on Aug 23, 2010 Male patient from UNITED STATES , weighting 189.6 lb, was treated with Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: cardiac flutter, diarrhoea, dyspnoea, haematocrit decreased, haemoglobin decreased, hypophagia, liver function test abnormal, nausea (What is nausea?), no therapeutic response. Mercaptopurine dosage: 375 Mg. During the same period patient was treated with METHOTREXATE (40 Mg) (View Methotrexate Review and Methotrexate Label ), TRETINOIN (270 Mg) (View Tretinoin Review and Tretinoin Label ). Patient was hospitalized.

6936009-3 | Anxiety, Obsessive-compulsive Disorder
on Aug 06, 2010 Female patient from , child 9 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), obsessive-compulsive disorder (What is obsessive-compulsive disorder?). Mercaptopurine dosage: 50 Mg.

6924260-8 | Blood Bilirubin Unconjugated Increased, Hyperbilirubinaemia, Hyperglycaemia
Patient was taking Mercaptopurine (View Usage). Patient had the following side effects: blood bilirubin unconjugated increased, hyperbilirubinaemia, hyperglycaemia on Aug 11, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 94.80 lb, . Mercaptopurine dosage: 1500 Mg. During the same period patient was treated with METHOTREXATE (65 Mg) (View Methotrexate Review and Methotrexate Label ), VINCRISTINE SULFATE (1.9 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ).

6924256-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Cholesterol Increased, Blood Glucose Increased, Blood Triglycerides Increased, Hyperbilirubinaemia
Adverse event was reported on Aug 11, 2010 by a Male patient taking Mercaptopurine (View Usage) (Dosage: 3800 Mg) . Location: UNITED STATES , weighting 225.5 lb, After Mercaptopurine was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood cholesterol increased, blood glucose increased, blood triglycerides increased, hyperbilirubinaemia. During the same period patient was treated with CYCLOPHOSPHAMIDE (4530 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (2712 Mg) (View Cytarabine Review and Cytarabine Label ), PEG L ASPARAGINASE (PEGASPARGASE, ONCOSPAR) (11275 Iu) (View Peg-l- Asparaginase (pegaspargase, Oncospar) Review and Peg-l- Asparaginase (pegaspargase, Oncospar) Label ), VINCRISTINE SULFATE (8 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), METHOTREXATE (60 Mg) (View Methotrexate Review and Methotrexate Label ), ATIGAL (View Atigal Review and Atigal Label ), BACTRIM (View Bactrim Review and Bactrim Label ), PREVACID (View Prevacid Review and Prevacid Label ).

6917318-0 | Pneumonia, Treatment Noncompliance, Unresponsive To Stimuli
on Jul 23, 2010 Male patient from UNITED STATES , 18 years of age, weighting 166.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), treatment noncompliance, unresponsive to stimuli. Mercaptopurine dosage: . During the same period patient was treated with CIMZIA (View Cimzia Review and Cimzia Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), TRAMADOL (View Tramadol Review and Tramadol Label ).

6915432-7 | Abdominal Distension, Adrenal Insufficiency, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cellulitis, Gamma-glutamyltransferase Increased, Herpes Simplex, Jaundice, Neutropenia
on Aug 06, 2010 Male patient from UNITED STATES , weighting 67.02 lb, was treated with Mercaptopurine (View Usage). Patient had the following side effects: abdominal distension, adrenal insufficiency, alanine aminotransferase increased, aspartate aminotransferase increased, cellulitis (What is cellulitis?), gamma-glutamyltransferase increased, herpes simplex (What is herpes simplex?), jaundice (What is jaundice?), neutropenia. Mercaptopurine dosage: 4500 Mg. During the same period patient was treated with METHOTREXATE (150 Mg) (View Methotrexate Review and Methotrexate Label ), VINCRISTINE SULFATE (2.8 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DEXAMETHASONE (60 Mg) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6915120-7 | Pancreatitis
Patient was taking Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: pancreatitis on Aug 05, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, weighting 210.5 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Mercaptopurine dosage: 50mg Daily Po. Patient was hospitalized.

6908405-1 | Blood Lactate Dehydrogenase Increased, Febrile Neutropenia, Hepatosplenic T-cell Lymphoma, Monocyte Percentage Increased, Night Sweats, No Therapeutic Response, Pancytopenia, Splenomegaly
Adverse event was reported on Jul 20, 2010 by a Male patient taking Mercaptopurine (View Usage) (Dosage: 25 Mg;qod) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 18 years of age, Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, febrile neutropenia, hepatosplenic t-cell lymphoma, monocyte percentage increased, night sweats, no therapeutic response, pancytopenia, splenomegaly. Patient was hospitalized.

6898828-1 | Pancreatitis Acute
on Jul 19, 2010 Female patient from NETHERLANDS , 57 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mercaptopurine (View Usage). Patient had the following side effects: pancreatitis acute. Mercaptopurine dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ).

6895368-0 | Abdominal Distension, Adrenal Insufficiency, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bilirubin Conjugated, Blood Bilirubin Increased, Cellulitis, Cough, Dyspnoea
on Jul 30, 2010 Male patient from UNITED STATES , weighting 67.02 lb, was treated with Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: abdominal distension, adrenal insufficiency, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated, blood bilirubin increased, cellulitis (What is cellulitis?), cough, dyspnoea. Mercaptopurine dosage: 4500 Mg. During the same period patient was treated with METHOTREXATE (150 Mg) (View Methotrexate Review and Methotrexate Label ), VINCRISTINE SULFATE (2.8 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DEXAMETHASONE (60 Mg) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6888334-2 | Pancreatitis Acute
Patient was taking Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute on Jul 28, 2010 from Additional patient health information: Female patient , 57 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Mercaptopurine dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ).

6836278-4 | Activated Partial Thromboplastin Time Prolonged, Jaundice
Adverse event was reported on Jul 12, 2010 by a Male patient taking Mercaptopurine (View Usage) (Dosage: 6525 Mg) . Location: UNITED STATES , weighting 177.5 lb, Patient had the following side effects: activated partial thromboplastin time prolonged, jaundice (What is jaundice?). During the same period patient was treated with METHOTREXATE (250 Mg) (View Methotrexate Review and Methotrexate Label ), PREDNISONE (1200 Mg) (View Prednisone Review and Prednisone Label ), VINCRISTINE SULFATE (6 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ).

6815319-4 | Blood Urine Present, Bone Marrow Failure, Epistaxis, Feeling Abnormal, Hypophagia, Pancytopenia, Skin Lesion
on Jul 01, 2010 Male patient from UNITED STATES , 59 years of age, weighting 137.6 lb, was diagnosed with colitis ulcerative and was treated with Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: blood urine present, bone marrow failure, epistaxis, feeling abnormal, hypophagia, pancytopenia, skin lesion. Mercaptopurine dosage: 150 Mg Every Day Po. Patient was hospitalized.

6784740-5 | Hepatosplenic T-cell Lymphoma
on Jun 08, 2010 Male patient from CANADA , 22 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatosplenic t-cell lymphoma. Mercaptopurine dosage: Maximum Dose 1.75 Mg/kg.

6766685-X | Anaemia, Blood Alkaline Phosphatase Increased, Cardiac Murmur, Coccidioidomycosis, Hypocalcaemia, Hyponatraemia, Renal Failure Acute
Patient was taking Mercaptopurine (View Usage). Patient had the following side effects: anaemia, blood alkaline phosphatase increased, cardiac murmur, coccidioidomycosis, hypocalcaemia, hyponatraemia, renal failure acute on Jun 07, 2010 from Additional patient health information: Male patient , 50 years of age, was diagnosed with crohn's disease (What is crohn's disease?), coccidioidomycosis and. Mercaptopurine dosage: 100 Mg. During the same period patient was treated with FLUCONAZOLE (1000 Mg) (View Fluconazole Review and Fluconazole Label ), MESALAZINE (2 G) (View Mesalazine Review and Mesalazine Label ), HYOSCYAMINE (1.47 Mg) (View Hyoscyamine Review and Hyoscyamine Label ), ADALIMUMAB (View Adalimumab Review and Adalimumab Label ), AMPHOTERICIN B (60 Mg) (View Amphotericin B Review and Amphotericin B Label ).

6765392-7 | Acne, Cushingoid
Adverse event was reported on Jun 02, 2010 by a Male patient taking Mercaptopurine (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: , 26 years of age, After Mercaptopurine was administered, patient had the following side effects: acne (What is acne?), cushingoid. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6764314-2 | Hepatosplenic T-cell Lymphoma
on Jun 08, 2010 Male patient from , 22 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatosplenic t-cell lymphoma. Mercaptopurine dosage: . Patient was hospitalized.

6763695-3 | Coccidioidomycosis
on May 31, 2010 Male patient from UNITED STATES , 50 years of age, was treated with Mercaptopurine (View Usage). Patient had the following side effects: coccidioidomycosis. Mercaptopurine dosage: 100 Mg/day. During the same period patient was treated with ADALIMUMAB (40 Mg Every 2 Weeks) (View Adalimumab Review and Adalimumab Label ), MESALAZINE (View Mesalazine Review and Mesalazine Label ), HYOSCYAMINE (View Hyoscyamine Review and Hyoscyamine Label ). Patient was hospitalized.

6744327-7 | Hypersensitivity, Nausea, Neuropathy Peripheral
Patient was taking Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: hypersensitivity, nausea (What is nausea?), neuropathy peripheral on May 24, 2010 from Additional patient health information: Male patient , 36 years of age, was diagnosed with b precursor type acute leukaemia, nausea (What is nausea?) and. Mercaptopurine dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

6743470-6 | Hypersensitivity, Pyrexia
Adverse event was reported on May 17, 2010 by a Male patient taking Mercaptopurine (View Usage) (Dosage: 60 Mg/m2/day) was diagnosed with acute lymphocytic leukaemia, antifungal prophylaxis, diabetes mellitus, hypothyroidism and. Location: UNITED STATES , 36 years of age, Patient experienced the following unwanted or unexpected effects: hypersensitivity, pyrexia. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), COTRIM (View Cotrim Review and Cotrim Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), INSULIN SUSPENSION ISOPHANE (View Insulin Suspension Isophane Review and Insulin Suspension Isophane Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ). Patient was hospitalized.

6740629-9 | Pancreatitis
on May 11, 2010 Female patient from JAPAN , child 3 years of age, weighting 35.27 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Mercaptopurine (View Usage). Patient had the following side effects: pancreatitis. Mercaptopurine dosage: . During the same period patient was treated with AZATHIOPRINE SODIUM (View Azathioprine Sodium Review and Azathioprine Sodium Label ).

6740627-5 | Alopecia, Blood Amylase Increased, Leukopenia, Lipase Increased
on May 11, 2010 Female patient from JAPAN , child 7 years of age, weighting 66.14 lb, was diagnosed with colitis ulcerative and was treated with Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: alopecia, blood amylase increased, leukopenia, lipase increased. Mercaptopurine dosage: . During the same period patient was treated with AZATHIOPRINE SODIUM (View Azathioprine Sodium Review and Azathioprine Sodium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6740622-6 | Blood Amylase Increased, Lipase Increased
Patient was taking Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: blood amylase increased, lipase increased on May 11, 2010 from JAPAN Additional patient health information: Female patient , 13 years of age, weighting 97.00 lb, was diagnosed with colitis ulcerative and. Mercaptopurine dosage: . During the same period patient was treated with AZATHIOPRINE SODIUM (View Azathioprine Sodium Review and Azathioprine Sodium Label ).

6738985-0 | Bone Marrow Failure, Cryptosporidiosis Infection, Iron Overload
Adverse event was reported on May 24, 2010 by a Female patient taking Mercaptopurine (View Usage) (Dosage: 25 Mg) . Location: UNITED STATES , weighting 118.2 lb, Patient had the following side effects: bone marrow failure, cryptosporidiosis infection, iron overload. During the same period patient was treated with METHOTREXATE (15 Mg) (View Methotrexate Review and Methotrexate Label ), PREDNISONE (300 Mg) (View Prednisone Review and Prednisone Label ), VINCRISTINE (4 Mg) (View Vincristine Review and Vincristine Label ).

6736621-0 | Blood Amylase Increased, Chills, Pyrexia, Vomiting, White Blood Cell Count Decreased
on May 20, 2010 Female patient from UNITED STATES , weighting 261.5 lb, was treated with Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: blood amylase increased, chills, pyrexia, vomiting, white blood cell count decreased. Mercaptopurine dosage: 4420 Mg. During the same period patient was treated with METHOTREXATE (177 Mg) (View Methotrexate Review and Methotrexate Label ), VINCRISTINE SULFATE (.87 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DEXAMETHASONE (65 Mg) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6734285-3 | Alopecia, Blood Amylase Increased, Leukopenia, Lipase Increased
on May 19, 2010 Female patient from , child 7 years of age, weighting 66.14 lb, was diagnosed with colitis ulcerative and was treated with Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, blood amylase increased, leukopenia, lipase increased. Mercaptopurine dosage: 125 Mg. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MESALAZINE (View Mesalazine Review and Mesalazine Label ).

6734284-1 | Pancreatitis
Patient was taking Mercaptopurine (View Usage). Patient had the following side effects: pancreatitis on May 19, 2010 from Additional patient health information: Female patient , child 3 years of age, weighting 35.27 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Mercaptopurine dosage: 50 Mg. During the same period patient was treated with MESALAZINE (View Mesalazine Review and Mesalazine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6734204-X | Blood Amylase Increased, Colitis Ulcerative, Lipase Increased
Adverse event was reported on May 19, 2010 by a Female patient taking Mercaptopurine (View Usage) (Dosage: 150 Mg) was diagnosed with colitis ulcerative and. Location: , 13 years of age, weighting 97.00 lb, After Mercaptopurine was administered, patient had the following side effects: blood amylase increased, colitis ulcerative, lipase increased. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MESALAZINE (View Mesalazine Review and Mesalazine Label ).

6713267-1 | Activated Partial Thromboplastin Time Abnormal, Disseminated Intravascular Coagulation, Fibrin D Dimer Increased, Haematemesis, Heart Rate Increased, Pancreatitis Acute, Prothrombin Time Abnormal, Urine Output Decreased
on May 05, 2010 Female patient from UNITED STATES , weighting 56.88 lb, was treated with Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time abnormal, disseminated intravascular coagulation, fibrin d dimer increased, haematemesis, heart rate increased, pancreatitis acute, prothrombin time abnormal, urine output decreased. Mercaptopurine dosage: 2075 Mg. During the same period patient was treated with METHOTREXATE (36 Mg) (View Methotrexate Review and Methotrexate Label ), PEG L ASPARAGINASE (PEGASPARGASE, ONCOSPAR) (2375 Mg) (View Peg-l-asparaginase (pegaspargase, Oncospar) Review and Peg-l-asparaginase (pegaspargase, Oncospar) Label ), VINCRISTINE SULFATE (1.4 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), ATIVAN (View Ativan Review and Ativan Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ELAVIL (View Elavil Review and Elavil Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6697344-X | Reversible Posterior Leukoencephalopathy Syndrome
on Apr 12, 2010 Female patient from UNITED STATES , 23 years of age, was diagnosed with systemic lupus erythematosus and was treated with Mercaptopurine (View Usage). Patient had the following side effects: reversible posterior leukoencephalopathy syndrome. Mercaptopurine dosage: . During the same period patient was treated with HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6697334-7 | Reversible Posterior Leukoencephalopathy Syndrome
Patient was taking Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: reversible posterior leukoencephalopathy syndrome on Apr 12, 2010 from UNITED STATES Additional patient health information: Female patient , 23 years of age, was diagnosed with systemic lupus erythematosus and. Mercaptopurine dosage: . During the same period patient was treated with HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6671753-7 | Alopecia, Heart Rate Irregular, Hepatic Enzyme Increased
Adverse event was reported on Apr 07, 2010 by a Male patient taking Mercaptopurine (View Usage) (Dosage: 75 Mg) was diagnosed with colitis ulcerative, asthma exercise induced and. Location: , child 12 years of age, Patient experienced the following unwanted or unexpected effects: alopecia, heart rate irregular, hepatic enzyme increased. During the same period patient was treated with CITRACAL (View Citracal Review and Citracal Label ), FOLIC ACID (1 Mg) (View Folic Acid Review and Folic Acid Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), SULFASALAZINE (3000 Mg) (View Sulfasalazine Review and Sulfasalazine Label ), FLOVENT (View Flovent Review and Flovent Label ), XOPENEX (View Xopenex Review and Xopenex Label ). Patient was hospitalized.

6660666-2 | Aura, Brain Scan Abnormal, Cerebrosclerosis, Complex Partial Seizures, Dizziness, Gliosis, Hypometabolism, Mental Impairment, Nausea
on Mar 09, 2010 Male patient from TURKEY , 15 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Mercaptopurine (View Usage). Patient had the following side effects: aura, brain scan abnormal, cerebrosclerosis, complex partial seizures, dizziness (What is dizziness?), gliosis, hypometabolism, mental impairment, nausea (What is nausea?). Mercaptopurine dosage: . During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (Intrathecal) (View Methotrexate Review and Methotrexate Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6645817-8 | Coagulation Time Shortened, Febrile Neutropenia, International Normalised Ratio Decreased, Thrombocytopenia
on Feb 13, 2009 Male patient from UNITED STATES , 81 years of age, was diagnosed with embolism and was treated with Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: coagulation time shortened, febrile neutropenia, international normalised ratio decreased, thrombocytopenia. Mercaptopurine dosage: 100 Mg; Qd; Po. During the same period patient was treated with ZYLOPRIM (300 Mg; Qd ;) (View Zyloprim Review and Zyloprim Label ), WARFARIN SODIUM (8.5 Mg; Qd;) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6609088-0 | Lung Infiltration, Pneumonia Fungal
Patient was taking Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: lung infiltration, pneumonia fungal on Feb 25, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 213.8 lb, . Mercaptopurine dosage: 1800 Mg. During the same period patient was treated with METHOTREXATE (15 Mg) (View Methotrexate Review and Methotrexate Label ), VINCRISTINE SULFATE (1 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DEXAMETHASONE (60 Mg) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6609085-5 | Hyperbilirubinaemia
Adverse event was reported on Feb 25, 2010 by a Male patient taking Mercaptopurine (View Usage) (Dosage: 2400 Mg) . Location: UNITED STATES , weighting 101.0 lb, Patient had the following side effects: hyperbilirubinaemia. During the same period patient was treated with METHOTREXATE (60 Mg) (View Methotrexate Review and Methotrexate Label ), PEG L ASPARAGINASE (PEGASPARGASE, ONCOSPAR) (7050 Iu) (View Peg-l-asparaginase (pegaspargase, Oncospar) Review and Peg-l-asparaginase (pegaspargase, Oncospar) Label ), VINCRISTINE SULFATE (6 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), CYCLOPHOSPHAMIDE (2820 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6596939-1 | Osteomyelitis, Stomatitis Necrotising
on Feb 09, 2010 Female patient from BRAZIL , 15 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mercaptopurine (View Usage). After Mercaptopurine was administered, patient had the following side effects: osteomyelitis, stomatitis necrotising. Mercaptopurine dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6596938-X | Osteomyelitis, Stomatitis Necrotising
on Feb 09, 2010 Female patient from BRAZIL , 15 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mercaptopurine (View Usage). Patient experienced the following unwanted or unexpected effects: osteomyelitis, stomatitis necrotising. Mercaptopurine dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6592817-2 | Accidental Exposure, Acute Myeloid Leukaemia
Patient was taking Mercaptopurine (View Usage). Patient had the following side effects: accidental exposure, acute myeloid leukaemia on Feb 15, 2010 from CANADA Additional patient health information: Male patient , 37 years of age, weighting 180.2 lb, was diagnosed with colitis ulcerative and. Mercaptopurine dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.